All stock lists Unlock the score
Outlook Therapeutics, Inc. (NASDAQ:OTLK)
US · Delayed Price · Currency is USD
0.50-0.02 (-3.70%)
Market cap
$122M
Insider Score
Analyst consensus
Listed since
Jun 14, 2016
Website
Insider Score
/ 100
OTLK Insider Score
Outlook Therapeutics, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
OTLK Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 9.00 K | 127.44 K | -1.21 M | -91.79 K | 1.51 M | 0.00 |
| Revenue Growth (YoY) | -99.40 % | — | — | — | — | — |
| Cost of Revenue | 17.00 K | 149.33 K | 29.63 K | 916.51 K | 439.81 K | 0.00 |
| Gross Profit | -8.00 K | -21.89 K | -1.24 M | -1.01 M | 1.07 M | 0.00 |
| SG&A Expense | 7.55 M | 9.50 M | 8.61 M | 10.33 M | 9.68 M | 7.98 M |
| R&D Expense | 3.25 M | 4.50 M | 3.63 M | 5.98 M | 7.13 M | 4.41 M |
| Operating Expenses | 10.80 M | 14.01 M | 12.25 M | 16.31 M | 16.81 M | 12.39 M |
| Operating Income | -10.81 M | -14.03 M | -13.48 M | -17.31 M | -15.75 M | -12.39 M |
| Pretax Income | -20.28 M | -4.45 M | -23.06 M | -14.85 M | -20.15 M | -46.35 M |
| Tax Provision | 41.00 K | 0.00 | 0.00 | -1.55 M | 0.00 | 2.80 K |
| Net Income | -20.32 M | -4.45 M | -23.06 M | -13.29 M | -20.15 M | -46.36 M |
| EPS (Basic) | -0.15 | -0.05 | -0.38 | -0.52 | -0.55 | -1.50 |
| EPS (Diluted) | -0.15 | -0.05 | -0.38 | -0.52 | -0.55 | -1.50 |
| Shares Outstanding | 136.74 M | 81.84 M | 60.21 M | 25.48 M | 36.96 M | 30.87 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.